CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Malievskaia Ekaterina 10% owner | Sale 10b5-1 | −25,750 | $8.96 | $231K | 4,008,130 |
| 2024-04-01 | Malievskaia Ekaterina 10% owner | Sale 10b5-1 | −25,750 | $8.96 | $231K | 4,010,404 |
| 2024-03-28 | Malievskaia Ekaterina 10% owner | Sale 10b5-1 | −25,750 | $8.65 | $223K | 4,033,880 |
| 2024-03-28 | Malievskaia Ekaterina 10% owner | Sale 10b5-1 | −25,750 | $8.65 | $223K | 4,036,154 |
| 2024-03-28 | Goldsmith George Jay 10% owner | Sale 10b5-1 | −25,750 | $8.65 | $223K | 4,036,154 |
| 2024-03-28 | Goldsmith George Jay 10% owner | Sale 10b5-1 | −25,750 | $8.65 | $223K | 4,033,880 |
| 2024-03-13 | Goldsmith George Jay Director | Sale 10b5-1 | −17,203 | $10.80 | $186K | 4,061,904 |
| 2024-03-13 | Goldsmith George Jay Director | Sale 10b5-1 | −17,203 | $10.80 | $186K | 4,059,630 |
| 2024-03-13 | Malievskaia Ekaterina Director | Sale 10b5-1 | −17,203 | $10.80 | $186K | 4,059,630 |
| 2024-03-13 | Malievskaia Ekaterina Director | Sale 10b5-1 | −17,203 | $10.80 | $186K | 4,061,904 |
| 2024-03-12 | Goldsmith George Jay Director | Sale 10b5-1 | −15,740 | $10.58 | $167K | 4,079,107 |
| 2024-03-12 | Goldsmith George Jay Director | Sale 10b5-1 | −15,740 | $10.58 | $167K | 4,076,833 |
| 2024-03-12 | Malievskaia Ekaterina Director | Sale 10b5-1 | −15,740 | $10.58 | $167K | 4,076,833 |
| 2024-03-12 | Malievskaia Ekaterina Director | Sale 10b5-1 | −15,740 | $10.58 | $167K | 4,079,107 |
| 2024-03-01 | Loxam Teri Chief Financial Officer | Grant or award | +62,718 | 62,718 | ||
| 2024-03-01 | Loxam Teri Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +117,643 | 117,643 | ||
| 2024-02-26 | Malievskaia Ekaterina Director | Sale 10b5-1 | −17,765 | $10.45 | $186K | 4,092,573 |
| 2024-02-26 | Malievskaia Ekaterina Director | Sale 10b5-1 | −17,765 | $10.45 | $186K | 4,094,847 |
| 2024-02-26 | Goldsmith George Jay Director | Sale 10b5-1 | −17,765 | $10.45 | $186K | 4,094,847 |
| 2024-02-26 | Goldsmith George Jay Director | Sale 10b5-1 | −17,765 | $10.45 | $186K | 4,092,573 |
Page 5 of 12 · 230 trades